Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine Eye Drops for Vernal Keratoconjunctivitis
NCT00426023Phase 3Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine 2% ophthalmic solution in Vernal Keratoconjunctivitis (VKC), sponsored by Università Campus Bio-Medico di Roma. Started Feb 2007; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT00426023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426023.